Delivery Order SPE2DR25D2014-SPE2DR26FA4H7
- Not listed
- The Defense Logistics Agency awarded a $1,797.24 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Epinephrine 0.3 mg auto-injector two-packs, with an ultimate completion date of January 27, 2026. This is a non-set-aside, competitively awarded contract with performance in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's parent company Cencora, Inc.'s substantial Indefinite Delivery Contract with DLA Troop Support Medical, valued at...
- The Defense Logistics Agency awarded a delivery order valued at $1,716.00 to AmerisourceBergen Drug Corp for the supply of Epinephrine 0.3 mg auto-injector 2-packs. This firm fixed-price delivery order was competitively awarded without set-aside designation and is scheduled for completion by January 29, 2026. The contractor, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement and fulfills this order through its parent...
- The Defense Logistics Agency awarded a delivery order valued at $6,140.21 to AmerisourceBergen Drug Corp for the supply of Epinephrine 0.3 mg auto-injector 2-packs. This is a firm fixed-price delivery order with an ultimate completion date of January 15, 2026, and represents a non-set-aside competitive award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving federal healthcare systems, including military and veteran medical...
- The Defense Logistics Agency awarded a $1,775.97 firm fixed-price delivery order to AmerisourceBergen Drug Corp for epinephrine 0.3 mg auto-injector 2-packs on December 16, 2025, with completion due by December 17, 2025. This non-set-aside contract is a child order issued under AmerisourceBergen's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The company, headquartered in Conshohocken, Pennsylvania,...
- The Defense Logistics Agency awarded a $3,081.23 delivery order to AmerisourceBergen Drug Corp on January 16, 2026, for the supply of Epinephrine 0.3 mg auto-injector two-packs. This firm fixed-price contract, with a completion date of January 20, 2026, was competitively awarded without set-aside restrictions and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's parent company Cencora, Inc.'s...
- The Defense Logistics Agency awarded a $1,797.24 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Epinephrine 0.3 mg auto-injector (two-pack) on January 15, 2026, with completion scheduled for January 16, 2026. This non-set-aside contract was competitively awarded and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp operates as a subsidiary of Cencora, Inc., a leading pharmaceutical distributor serving federal...
- The Defense Logistics Agency awarded a $1,907.74 delivery order to AmerisourceBergen Drug Corp for epinephrine 0.15 mg auto-injector two-packs, with completion expected by September 17, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and represents a single delivery order under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical. The product will be delivered to the company's facility in Conshohocken, Pennsylvania,...
- The Defense Logistics Agency awarded a delivery order valued at $1,610.07 to AmerisourceBergen Drug Corp for Epinephrine 0.3 mg auto-injector (2-pack) with a firm fixed price contract structure. The order was competitively awarded without set-aside designation and carries an ultimate completion date of July 23, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery...
- The Defense Logistics Agency awarded a delivery order valued at $1,209.24 to AmerisourceBergen Drug Corp for the supply of Epinephrine 0.3 mg auto-injector packs (2-count). This competitively awarded, non-set-aside delivery order was issued on June 17, 2025, with an ultimate completion date of June 18, 2025, and operates under firm fixed pricing. The product will be delivered to the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate office...
- The Defense Logistics Agency awarded a $1,856.40 firm fixed price delivery order to AmerisourceBergen Drug Corp for epinephrine 0.3 mg auto-injector two-packs on September 18, 2025, with completion targeted for September 19, 2025. This non-set-aside competitive award is issued under AmerisourceBergen's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The delivery order will be fulfilled at...
- SPE2DR25D2014Indefinite Delivery Contract
- SPE2DR25D2014-SPE2DR26FA4H7Delivery Order
The Defense Logistics Agency awarded a $1,797.24 delivery order to AmerisourceBergen Drug Corp for epinephrine 0.3 mg auto-injector two-packs, with delivery completed by February 4, 2026. This competitively awarded, firm fixed-price contract carries no set-aside designation and is being fulfilled from the contractor's place of performance in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp operates as a subsidiary of parent company Cencora, Inc., a major pharmaceutical distributor specializing in supplying critical medical products to federal healthcare systems. This delivery order is executed under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. This prime IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including specialty medications, brand-name and generic drugs, vaccines, and medical devices across multiple therapeutic domains. The contract supports critical medical procurement for the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.8k | 2/2/26 |